Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse D Bloom

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|July 20, 2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutininFrances C Welsh, Rachel T Eguia, Juhye M Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza seasonSusanne L Linderman, Benjamin S Chambers, Seth J Zost, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutininFrances C Welsh, Rachel T Eguia, Juhye M Lee, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selectionCaroline Kikawa, John Huddleston, Sam A Turner, et al.
Science (New York, N.Y.)|July 20, 2022
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal modelsAlexander A Cohen, Neeltje van Doremalen, Allison J Greaney, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal modelsAlexander A Cohen, Neeltje van Doremalen, Allison J Greaney, et al.
Mbio|September 14, 2021
Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian HamstersWen Su, Sin Fun Sia, Aaron J Schmitz, et al.
Science Translational Medicine|June 10, 2026
A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralizationAxel A Guzmán-Solís, Mohamed Ouizougun-Oubari, Olivier Escaffre, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|July 20, 2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutininFrances C Welsh, Rachel T Eguia, Juhye M Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza seasonSusanne L Linderman, Benjamin S Chambers, Seth J Zost, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutininFrances C Welsh, Rachel T Eguia, Juhye M Lee, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selectionCaroline Kikawa, John Huddleston, Sam A Turner, et al.
Science (New York, N.Y.)|July 20, 2022
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal modelsAlexander A Cohen, Neeltje van Doremalen, Allison J Greaney, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal modelsAlexander A Cohen, Neeltje van Doremalen, Allison J Greaney, et al.
Mbio|September 14, 2021
Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian HamstersWen Su, Sin Fun Sia, Aaron J Schmitz, et al.
Science Translational Medicine|June 10, 2026
A cocktail of human mAbs targeting the henipavirus fusion and receptor binding proteins provides cross-species neutralizationAxel A Guzmán-Solís, Mohamed Ouizougun-Oubari, Olivier Escaffre, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Pageof 26